Peter Attia· MD
they carry out this trial it's intended to be a 10-year clinical trial and they it's fourteen hundred and forty one patients they're relatively recent onset type one diabetes they're largely late teen and adults and it's a very difficult trial to do because there were no established best practices to achieve near normal blood glucoses at the time